Scientists Raise Concerns about Arthritis Drug Bextra

NPR | By Richard Knox

Published November 11, 2004 at 12:00 AM EST

Scientists say the arthritis drug Bextra may pose increased risk of cardiovascular troubles. Bextra is related to Vioxx, which was pulled off the market in September for the same reason. Now, doctors worry that all related drugs could cause similar problems. Hear NPR's Richard Knox.

Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

See stories by Richard Knox

SUSTAIN what matters. BUILD what’s next.

With federal funding eliminated, WKAR relies more than ever on community support to sustain essential services that remain freely available to everyone in mid-Michigan. Your support helps shape what comes next for public media in our region. The best way to support WKAR is by becoming a sustaining member today or by upgrading your current gift. Support WKAR TV Here | Support WKAR Radio Here.